$country= Comparative statistics by cancer registry - SurvCan

Comparative statistics by cancer registry

Registry: Comparative statistics by cancer site

Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site

(Singapore, 1993-1997 cases followed-up until 2001)

Click on cancer site (ICD-10 code) for comparison
%No. of excluded casesIncluded cases
SiteICD-10Total registeredHVDCODCONo. follow-upOthersTotal%No.%
C01-02Tongue124100.00.004043.212096.8
C03-06Oral cavity13897.80.003032.213597.8
C07-08Salivary gland9598.90.002688.48791.6
C09Tonsil4097.50.002025.03895.0
C11Nasopharynx145998.80.00532553.8140496.2
C12-13Hypopharynx9298.90.002022.29097.8
C15Oesophagus45992.41.5751132.844697.2
C16Stomach219194.01.1254125914.2210095.8
C17Small intestine8894.30.003589.18090.9
C18Colon262893.30.82079281274.8250195.2
C19-20Rectum183197.20.23669784.3175395.7
C21Anus5398.10.000000.053100.0
C22Liver165526.85.2861901056.3155093.7
C23-24Gall bladder29973.91.7550103.328996.7
C25Pancreas53641.83.41833244.551295.5
C30-31Nose/Sinuses7398.60.001122.77197.3
C32Larynx32696.90.00141154.631195.4
C33-34Lung438682.41.7745631333.0425397.0
C37-38Other thoracic organs6589.21.511023.16396.9
C40-41Bone8096.31.312161923.86176.3
C43Melanoma skin66100.00.006069.16090.9
C44Other skin116399.50.11124112610.8103789.2
C45Mesothelioma34100.00.000000.034100.0
C47+C49Connective tissue18594.61.127101910.316689.7
C48Peritoneum4486.40.001349.14090.9
C50Breast339598.90.27147371915.6320494.4
C51Vulva38100.00.003037.93592.1
C53Cervix103798.70.33500535.198494.9
C54Corpus uteri53297.71.163211499.248390.8
C56Ovary78796.60.653529698.871891.2
C60Penis42100.00.001012.44197.6
C61Prostate79695.10.54391445.575294.5
C62Testis8795.40.00661213.87586.2
C64Kidney38781.71.35121184.736995.3
C65Renal pelvis4595.60.001012.24497.8
C67Urinary bladder52096.20.00204244.649695.4
C70-72Brain & nervous system31481.54.11338247.629092.4
C73Thyroid58897.60.00331345.855494.2
C74Adrenal gland3281.33.1112412.52887.5
C81Hodgkin lymphoma79100.00.006067.67392.4
C82-85+C96Non-Hodgkin lymphoma834100.00.76380445.379094.7
C90Multiple myeloma167100.03.662084.815995.2
C91Lymphoid leukaemia209100.00.513041.920598.1
C92-94Myeloid leukaemia408100.00.73150184.439095.6
C95Leukaemia unspecified80100.07.5620810.07290.0


Other tables available for this registry:
- Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table2b: Number and proportion of cases by vital status and median follow-up (in months) by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Singapore, 1993-1997 cases followed-up until 2001)
- Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Singapore, 1993-1997 cases followed-up until 2001)
- Table5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Singapore, 1993-1997)
- Table6: Comparison of 5-year absolute and relative survival of cases diagnosed between 1988-1992 and 1993-1997 (Singapore)
- Table7b: Number of cases by cancer site and calendar period (Singapore Cancer Registry, 1968-1997)
- Table8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period (Singapore, 1968-1997 cases followed-up until 1997)
- Table9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period (Singapore, 1968-1997 cases followed-up until 1997)




Registry chapter:


Consult the chapter in Cancer survival in developping countries (Volume II)